The hollow fibre model in cancer drug screening: the NCI experience.
about
Guidelines for the welfare and use of animals in cancer research.What do, can and should we learn from models to evaluate potential anticancer agents?The Hollow Fibre Assay as a model for in vivo pharmacodynamics of fluoropyrimidines in colon cancer cellsDirect in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients.Use of the in vivo hollow fiber assay in natural products anticancer drug discovery.Experimental mouse models for hepatocellular carcinoma research.Preclinical development of molecular-targeted agents for cancer.Novel approaches to glioma drug design and drug screening.Animal models of pancreatic cancer for drug research.
P2860
Q33903753-39B8DD8F-92D7-43B1-B11E-E040D395FD5CQ36430731-97625347-A663-4AE5-9359-03530E672B4EQ36610507-B8EC36C7-7294-4C00-9A46-5CC8EFCA7D39Q37324241-137029BE-7463-4623-9FA4-D5342EA44CA9Q37374872-FF0F0F78-6EAA-4E97-A875-924F961023B4Q37574072-8055D6D4-C6A2-493C-83E0-97AAE332E6FAQ37816960-21F12595-0B0F-4ADB-B813-C24237BBBD00Q38112184-DADD8017-824A-4B4A-9A10-EABFD81A9F5BQ52915643-AB8DD523-CAB5-449E-B914-EC537B5EB21D
P2860
The hollow fibre model in cancer drug screening: the NCI experience.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The hollow fibre model in cancer drug screening: the NCI experience.
@en
type
label
The hollow fibre model in cancer drug screening: the NCI experience.
@en
prefLabel
The hollow fibre model in cancer drug screening: the NCI experience.
@en
P2093
P1476
The hollow fibre model in cancer drug screening: the NCI experience.
@en
P2093
Hollingshead M
Sausville EA
P304
P356
10.1016/J.EJCA.2003.11.029
P577
2004-04-01T00:00:00Z